1. Young JL, Smith MA, Roffers SD, et al. Retinoblastoma.
In: Reis LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence
and Survival among Children and Adolescents: United States SEER
Program 1975-1995. Bethesda, MD: National Cancer Institute;
1999:73-78. NIH Pub. No.99-4649.
2. Knudson AG Jr. Mutation and cancer: statistical study of
retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820-823.
3. Harbour JW. Overview of RB gene mutations in patients with
retinoblastoma. Implications for clinical genetic testing. Ophthalmology. 1998;105
(8):1442-1447.
4. Valverde JR, Alonso J, Palacios I, et al.
RB1 gene
mutations up-date, a meta-analysis based on 932 reported mutations
available in a searchable database.
BMC Genet. 2005;6:53.
[PubMed: 16269091]
5. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers
after radiotherapy in long term survivors of retinoblastoma: an
extended follow-up. J Clin Oncol. 2005;23(10):2272-2279.
6. Draper GJ, Sanders BM, Brownhill PA, et al. Patterns of risk
of hereditary retinoblastoma and applications to genetic counseling. Br
J Cancer. 1992;66(1):211-219.
7. McLean I, Burnier M, Zimmerman L, Jakobiec F. Tumors of the
retina. In: McLean IW, Burnier M, Zimmerman L, et al, eds. Atlas
of Tumor Pathology. Tumors of the Eye and Ocular Adnexa. Washington,
DC: Armed Forces Institute of Pathology; 1994:100-135.
8. Abramson DH, Frank CM, Susman M, et al. Presenting signs
of retinoblastoma. J Pediatr. 1998;132(3):505-508.
9. Shields CL, Shields JA. Differential diagnosis of retinoblastoma. Retina. 1991;11(2):232-243.
10. Antoneli CB, Ribeiro Kde C, Sakamoto LH, et al. Trilateral
retinoblastoma. Pediatr Blood Cancer. 2007;48(3):306-310.
11. Shields CL, Shields JA. Basic understanding of current classification
and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17(3):228-234.
12. Demirci H, Shields CL, Shields JA. Long term visual outcome
following chemoreduction for retinoblastoma. Arch Ophthalmol. 2005;123(11):
1525-1530.
13. Honavar SG, Singh AD, Shields CL, et al. Postenucleation
adjuvant therapy in high risk retinoblastoma. Arch Ophthalmol. 2002;120(7):923-931.
14. Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment
of metastatic retinoblastoma. Cancer. 2000;89(10):2117-2121.
15. Leal-Leal CA, Rivera-Luna R, Flores-Rojo M, et al. Survival
in extra-orbital metastatic retinoblastoma: treatment results. Clin
Transl Oncol. 2006;8(1):39-44.
16. Li FP, Abramson DH, Tarone RE, et al. Hereditary retinoblastoma,
lipoma, and second primary cancers. J Natl Cancer Inst. 1997;89(1):83-84.
17. Yue NC, Benson ML. The hourglass deformity as a consequence
of orbital irradiation for bilateral retinoblastoma.
Pediatr
Radiol. 1996;26: 421-423.
[PubMed: 8657482]